Welcome to LookChem.com Sign In|Join Free

CAS

  • or

701917-04-6

Post Buying Request

701917-04-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

701917-04-6 Usage

Physical state

Yellow crystalline solid

Common uses

Building block for organic synthesis and pharmaceutical research, potential anti-inflammatory agent

Handling precautions

May pose hazards to human health and the environment if not properly handled and disposed of.

Check Digit Verification of cas no

The CAS Registry Mumber 701917-04-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,1,9,1 and 7 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 701917-04:
(8*7)+(7*0)+(6*1)+(5*9)+(4*1)+(3*7)+(2*0)+(1*4)=136
136 % 10 = 6
So 701917-04-6 is a valid CAS Registry Number.

701917-04-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-nitro-1-phenylpyrazol-3-amine

1.2 Other means of identification

Product number -
Other names 3-amino-4-nitro-1-phenyl-1H-pyrazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:701917-04-6 SDS

701917-04-6Relevant articles and documents

HETERO-HALO INHIBITORS OF HISTONE DEACETYLASE

-

, (2017/01/26)

This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula I, II or any of Compounds 100-128 or any of those in Tables 2 or 3) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.

PHOSPHORUS DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS

-

Page/Page column 133-134, (2008/06/13)

The present invention relates to a novel class of phosphorus derivatives. The phosphorus compounds can be used to treat cancer. The phosphorus compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differe

SUBSTITUTED NICOTINAMIDE COMPOUNDS

-

Page/Page column 69-70, (2010/11/27)

The present invention relates to a novel class of substituted nicotinamides.. These compounds can inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplast

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 701917-04-6